Stock WINDLAS WINDLAS BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Windlas Biotech Limited

Equities

WINDLAS

INE0H5O01029

Market Closed - NSE India S.E.
Other stock markets
 07:43:54 2024-05-31 EDT 		5-day change 1st Jan Change
632.1 INR +0.29% Intraday chart for Windlas Biotech Limited +2.25% +47.43%
05-20 Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
05-20 Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Windlas Biotech Commissions New Injectible Manufacturing Unit
MT
Windlas Biotech Limited Commissions Its Injectable Facility
CI
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Windlas Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23
CI
Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2022-23
CI
Windlas Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Windlas Biotech's Consolidated Profit Slips in Fiscal Q4
MT
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Windlas Biotech Limited Recommends Dividend
CI
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.
CI
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.
CI
Windlas Biotech Limited's Equity Buyback announced on November 8, 2022 has closed with 867,747 shares, representing 3.98% for INR 217.97 million.
CI
Windlas Biotech's Consolidated Profit Climbs in Fiscal Q3
MT
Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer
CI
Windlas Biotech Appoints CEO
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WINDLAS Stock
  4. News Windlas Biotech Limited